Sign In
Buy TXG
$47.27
-2.16 (-4.37%)
At Close: Jul 31, 2026
10x Genomics: Recent Performance Amplifies My Bullish Conviction
10:46am, Friday, 08'th Sep 2023
10x Genomics reported impressive Q2 performance with revenue growing by 28% YoY to reach $147M. The company's growth is driven by strong performance in both single-cell and spatial biology portfolios.
10x Genomics (TXG) Reports Q2 Earnings: What Key Metrics Have to Say
11:16pm, Thursday, 03'rd Aug 2023
While the top- and bottom-line numbers for 10x Genomics (TXG) give a sense of how the business performed in the quarter ended June 2023, it could be worth looking at how some of its key metrics compar
10x Genomics (TXG) Reports Q2 Loss, Tops Revenue Estimates
08:16pm, Thursday, 03'rd Aug 2023
10x Genomics (TXG) came out with a quarterly loss of $0.53 per share versus the Zacks Consensus Estimate of a loss of $0.39. This compares to loss of $0.57 per share a year ago.
Goldman Sachs Maintains 10x Genomics Inc – (TXG) Sell Recommendation
11:56pm, Friday, 14'th Jul 2023
Fintel reports that on July 13, 2023, Goldman Sachs maintained coverage of 10x Genomics Inc – (TXG) with a Sell recommendation.
10x Genomics: Growth Outweighing The Risks
10:55am, Saturday, 24'th Jun 2023
10x Genomics has been on my Compounding Healthcare “Bio Boom” speculative portfolio watch list since its IPO back in 2019. I believe 10x Genomics is becoming an entrenched name. After performing s
Red-Hot Quality Opportunities in Genomics
02:21pm, Thursday, 22'nd Jun 2023
The health care sector is currently undergoing a remarkable transformation. The recent focus on genomics has empowered medical professionals to diagnose patients more objectively and adopt proactive m
CEO Serge Saxonov Sells 2,602 Shares of 10x Genomics Inc (TXG)
10:24pm, Thursday, 25'th May 2023
On May 23, 2023, Serge Saxonov, CEO of 10x Genomics Inc ( TXG , Financial), sold 2,602 shares of the company's stock. This insider sell comes amidst a year of insider transactions that have seen Saxon
How 10x Genomics Provides A View Into The Body's Cellular Warfare
11:43am, Thursday, 25'th May 2023
It could be an inflection year for 10x Genomics, one analyst says. TXG stock bounded off a low in October and is now on a seven-month sprint.
3 DNA Stocks to Buy for the Synthetic Biology Revolution
04:05pm, Sunday, 14'th May 2023
Biology is the study of life. And synthetic biology is the creation of new life for new purposes.
A Deep Dive Into 10x Genomics, A Promising Portfolio
01:53am, Thursday, 06'th Apr 2023
10x Genomics develops cutting-edge platforms for single-cell and spatial analysis, driving advances in disease research and drug discovery. Despite market fluctuations, their strong product pipeline i
Investment in procedural medical devices is safer for valuation, says E Squared's Les Funtleyder
02:12pm, Thursday, 30'th Mar 2023
Les Funtleyder, portfolio manager for E Squared Capital Management, joins 'The Exchange' to discuss big cap pharma's Q1 performance, the dollar weakness contributing to biotech gains, and investment o
10x Genomics to Present at the 43rd Annual Cowen Healthcare Conference
04:30pm, Wednesday, 22'nd Feb 2023
PLEASANTON, Calif. , Feb. 22, 2023 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a life sciences leader focused on mastering biology to advance human health, today announced the company will be pa
10x Genomics, Inc. (TXG) Q4 2022 Earnings Call Transcript
09:49pm, Wednesday, 15'th Feb 2023
10x Genomics, Inc. (NASDAQ:TXG ) Q4 2022 Earnings Conference Call February 15, 2023 4:30 PM ET Company Participants Cassie Corneau - Head, Investor Relations & Strategic Finance Serge Saxonov - Chief
10x Genomics (TXG) Reports Q4 Loss, Tops Revenue Estimates
06:49pm, Wednesday, 15'th Feb 2023
10x Genomics (TXG) delivered earnings and revenue surprises of 48.28% and 6.50%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
3 CRISPR Stocks to Buy Now Or You'll Be Kicking Yourself Later
12:58pm, Thursday, 02'nd Feb 2023
CRISPR is an acronym which refers to a series of DNA sequences in bacteria and other organisms. Scientists have begun editing genes, including CRISPR, to try to improve human health.
